sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Pulmonary Drug Delivery Systems Market Growth 2019-2024

Global Pulmonary Drug Delivery Systems Market Growth 2019-2024

Home / Categories / Healthcare
Global Pulmonary Drug Delivery Systems Market Growth 2019-2024
Global Pulmonary Drug Delivery Systems...
Report Code
RO1/109/1329

Publish Date
04/Feb/2019

Pages
162
PRICE
$ 3660/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5490/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7320/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.
As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.

According to this study, over the next five years the Pulmonary Drug Delivery Systems market will register a 5.3% CAGR in terms of revenue, the global market size will reach USD 3490 million by 2024, from USD 2560 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pulmonary Drug Delivery Systems business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.

This study considers the Pulmonary Drug Delivery Systems value and volume generated from the sales of the following segments-

Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
COPD
Asthma
Others

This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pulmonary Drug Delivery Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pulmonary Drug Delivery Systems market by identifying its various subsegments.
Focuses on the key global Pulmonary Drug Delivery Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pulmonary Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pulmonary Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com